Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alicia Serrano

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Annals of Hematology|January 7, 2021
Building a network of TP53 and IGHV testing reference centers across Spain: the Red53 initiativeFrancesc Bosch, Blanca Navarro, Marta Crespo, et al.
American Journal of Cancer Research|March 10, 2023
Prognostic value of genetic alterations and <sup>18</sup>F-FDG PET/CT imaging features in diffuse large B cell lymphomaBlanca Ferrer-Lores, Jose Lozano, Almudena Fuster-Matanzo, et al.
Clinical Cardiology|April 3, 2018
Changes in myocardial iron content following administration of intravenous iron (Myocardial-IRON): Study designGema Miñana, Ingrid Cardells, Patricia Palau, et al.
Ejhaem|March 20, 2025
Clinical Impact of CD19 Expression Assessed by Quantitative PCR in Lymphoma Patients Undergoing CAR-T TherapyRafael Hernani, Laura Ventura, Begoña Heras, et al.
Journal of the American Heart Association|February 19, 2020
Noninvasive Imaging Estimation of Myocardial Iron Repletion Following Administration of Intravenous Iron: The Myocardial-IRON TrialJulio Núñez, Gema Miñana, Ingrid Cardells, et al.
EJNMMI Research|November 20, 2024
Predicting survival, neurotoxicity and response in B-cell lymphoma patients treated with CAR-T therapy using an imaging features-based modelBlanca Ferrer-Lores, Alfonso Ortiz-Algarra, Alfonso Picó-Peris, et al.
The Science of the Total Environment|February 5, 2022
Environmental drivers of the seasonal exposure to airborne Alternaria spores in SpainAntonio Picornell, Jesús Rojo, M Mar Trigo, et al.
Hemasphere|January 22, 2025
Detection of clinically relevant variants in the <i>TP53</i> gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLLSarka Pavlova, Jitka Malcikova, Lenka Radova, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Annals of Hematology|January 7, 2021
Building a network of TP53 and IGHV testing reference centers across Spain: the Red53 initiativeFrancesc Bosch, Blanca Navarro, Marta Crespo, et al.
American Journal of Cancer Research|March 10, 2023
Prognostic value of genetic alterations and <sup>18</sup>F-FDG PET/CT imaging features in diffuse large B cell lymphomaBlanca Ferrer-Lores, Jose Lozano, Almudena Fuster-Matanzo, et al.
Clinical Cardiology|April 3, 2018
Changes in myocardial iron content following administration of intravenous iron (Myocardial-IRON): Study designGema Miñana, Ingrid Cardells, Patricia Palau, et al.
Ejhaem|March 20, 2025
Clinical Impact of CD19 Expression Assessed by Quantitative PCR in Lymphoma Patients Undergoing CAR-T TherapyRafael Hernani, Laura Ventura, Begoña Heras, et al.
Journal of the American Heart Association|February 19, 2020
Noninvasive Imaging Estimation of Myocardial Iron Repletion Following Administration of Intravenous Iron: The Myocardial-IRON TrialJulio Núñez, Gema Miñana, Ingrid Cardells, et al.
EJNMMI Research|November 20, 2024
Predicting survival, neurotoxicity and response in B-cell lymphoma patients treated with CAR-T therapy using an imaging features-based modelBlanca Ferrer-Lores, Alfonso Ortiz-Algarra, Alfonso Picó-Peris, et al.
The Science of the Total Environment|February 5, 2022
Environmental drivers of the seasonal exposure to airborne Alternaria spores in SpainAntonio Picornell, Jesús Rojo, M Mar Trigo, et al.
Hemasphere|January 22, 2025
Detection of clinically relevant variants in the <i>TP53</i> gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLLSarka Pavlova, Jitka Malcikova, Lenka Radova, et al.
Pageof 4